Selective Involvement of Keratins K1 and K10 in the Cytoskeletal Abnormality of Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)  by Ishida-Yamamoto, Akemi. et al.
Selective Involvement of Keratins Kl and Kl0 in the 
Cytoskeletal Abnormality ofEpidermolytic 
Hyperkeratosis (Bullous Congenital Ichthyosiform 
Erythroderma) 
Akemi Ishida-Yamamoto, John A. McGrath, Mary R. Judge, Irene M. Leigh, E. Birgitte Lane, and Robin A. J. Eady 
Department of Cell Pathology (AI-Y, JAM, RAJE), St. John's Institute of Dermatology, United Medical and Dental Schools, St. 
Thomas's Hospital, London; Department of Dermatology (MRJ), The Hospital for Sick Children, London; Experimental Dermatology 
Laboratory (IML), The Royal London Hospital, London; and CRC Cell Structure Research Group (EBL), Department of 
Biochemistry, Universiry of Dundee, Dundee, U.K. 
Aggregation of tonofilaments within epidermal keratino-
cytes is a characteristic histologic feature of epidermolytic 
hyperkeratosis including the generalized form known as bul-
l~us ~on?enital ichthyosiform erythroderma. The histologic 
dlStnbutlOn and the keratin composition of the altered tono-
fi.la~nents were investigated to determine whether the aggre-
gation was specific to any particular keratin{s}. Skin samples 
~rom seven patients and one mid-trimester fetus with general-
Ized epidermolytic hyperkeratosis , and from one patient with 
a.localized or "nevoid" form of epidermolytic hyperkerato-
SIS, were analyzed by using various microscopical and immu-
nocytochemical methods. A conjunctival sample and cul-
tured epidermal keratinocytes from one patient with 
~eneralized epidermolytic hyperkeratosis were also exam-
Ined by electron microscopy and immunocytochemistry. Ul-
tr~structurally, tonofi.lament aggregates were distributed 
wlthl11 the suprabasal stratified epithelial cell layers of the 
E pidermolytic hyperkeratosis is a term that is used to de-scribe a composite of histologic features that have been found to be associated with a number of congenital [1-13] and acquired [14] skin disorders. These features in-h c1ude acanthosis, papillomatosis, hyper granulosis, and 
. yperkeratosis, to varying degrees. An especially distinctive feature 
IS the presence of vacuolization of the spinous and granular epider-
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epidermis, of the infundibular part of outer root sheaths, and 
of the sebaceous ducts and sweat ducts, selectively following 
the known distribution pattern of keratins Kl and KlO. The 
abnormal tonofilaments were not found in any other cutane-
ous epithelia, in co~unctival epithelium, or in cultured kera-
tinocytes, where Kl and KlO are absent or only minimally 
expressed. Immunoelectron microscopy showed that among 
the keratins detected in suprabasal epidermolytic hyperkera-
tosis epidermis {Kl/KS/KlO/Kl4/Kl6}, the aggregated 
tonofilaments predominant! y expressed K land K 1 0 rather 
than other keratins. These results suggest that the keratin 
filament abnormality in epidermolytic hyperkeratosis prin-
cipally involves Kl and KlO and raise the question whether 
epidermolytic hyperkeratosis might be primarily a disorder 
of one or both of these keratins. ] Invest Dermatol 99: 19 - 26, 
1992 
mal layers associated with numerous, and often large, intracellular 
granules, which have been shown by electron microscopy mainly to 
consist of clumps of tonofilaments. 
Epidermolytic hyperkeratosis has long been recognized as the 
characteristic histologic pattern associated with an autosomal domi-
nant form of ichthyosis, namely, bullous congenital ichthyosiform 
erythroderma of Brocq (BCIE) [1-4,11,12]' and the term has be-
c?me widely adopted to ~escribe this clinicopathologic entity, espe-
CIally 111 the Amencan ltterature [1,15-17]. We have decided to 
retain the name in this context for Sithplicity; in this article, we use 
the term epidermolytic hyperkeratosis in a narrow sense to refer to 
typical BCIE, and to its localized form [18-20], which possibly 
results from somatic mosaicism [12,21]. 
It is well recognized that epidermolytic hyperkeratosis is inher-
ited by autosomal dominant transmission, but little is known about 
any underlying molecular abnormalities and how they may relate to 
the cutaneous changes. Abnormalities of keratin, filaggrin, and a 
lysosomal enzyme have all been reported [22 - 25] . In addition, auto-
radiographic studies using tritiated thymidine have revealed in-
creased epidermal cell proliferation a~d shortened transit time [26]. 
Tonofilament. aggregation IS the earliest morphologic abnormality 
to be recogl1lzed and precedes the other distinct morphologic 
changes ltsted above. TillS tonofilament abnormality has also been 
observed i~ skin samples from fetuses affected with BCIE during 
the mld-tnmester, even before the formation of keratohyalin gran-
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Table I. Epidermolytic Hyperkeratosis (EH) Examined in the Present Study 
Case Biopsy 
Number" Sex Sites 
1 M Axilla 
2 F Forearm 
Trunk 
3 M Back 
4 M Thigh 
5 F Thigh 
6 M Trunk 
7 F Knee 
8 M Back 
Age 
11 months 
37 years 
20 weeks gestation 
9 years 
5 d 
23 years 
14 years 
44 years 
30 years 
Investigationsb 
LM,EM 
LM,I-LM 
LM, EM, I-LM 
LM,EM 
LM, EM, I-LM 
LM, EM, I-LM, I-EM 
LM, EM, I-LM, I-EM 
LM, EM, I-LM, I-EM 
LM, EM, I-LM, I-EM 
Notes 
Two offspri n g also affected 
Fetus of case 2 
Son has EH 
Etretinate treated (0.75 mg/kg/day) 
Localized; son is case 6 
• Case 2 and her fetus were previously reported as an example of prenatal diagnosis of EH [27]. 
b LM, light microscopy; EM, electron microscopy; I-LM, light microscopic immunocytochemistry; I-EM, immunoelectron microscopy. 
ules and stratum corneum [25,27]. Therefore, it is possible that this 
cytoskeletal abnormality is a primary phenomenon and is a direct 
manifestation of the underlying genetic defect in epidermolytic 
hyperkeratosis. 
Recently, by histologic and immunoelectron microscopic analy-
sis, we have found that a similar form of tonofilament aggregation 
that occurs in another genetic skin disorder, the Dowling-Meara 
type of epidermolysis bullosa simplex (DM-EBS), is likely to be 
associated with an abnormality of the keratin pair K5jK14 [28]. It 
has also been reported that transgenic mice expressing a mutant K 14 
gene showed tonofilament aggregation and intraepidermal blister-
ing similar to that occurring in human DM-EBS [29] and point 
mutations in K14 genes have been found in two DM-EBS patients 
[30] . These data, suggesting the exis tence of genodermatoses pri-
marily caused by abnormalities of keratins, prompted us to examine 
the histologic distribution and keratin composition of the tonofila-
ment aggregates in epidenTIolytic hyperkeratosis to see whether it 
might also be a genetic disorder of particular keratins. 
MATERIALS AND METHODS 
Patients and Tissue Samples Tissue samples from eight pa-
tients with epidermolytic hyperkeratosis were examined (Table I). 
The diagnosis in all patients was based on both clinical and histo-
logic criteria. Seven patients had generalized skin involvement that 
was typical ofBCIE and one case (case 7), the mother of case 6, had 
more localized lesions. Involved skin from all cases and conjunctival 
samples from one BCIE (case 8) were taken under local anesthesia 
with informed consent. Skin samples were also obtained from a 
fetus in case 2 at 20 weeks gestational age as previously described 
[27], further samples were obtained after the fetus was aborted 
at 21 weeks, following prenatal diagnosis of epidermolytic 
hyperkeratosis. 
Keratinocyte Culture Keratinocytes derived from a skin biopsy 
(case 8) were cultured using the 3T3 feeder layer technique accord-
ing to standard methods [31,32] . Confluent cultures were removed 
as intact sheets with Dispase (Boehringer Mannheim, East Sussex, 
U .K.). Some of the detached cultured keratinocyte sheets were pro-
cessed for electron microscopy and the remainder was fixed with 
periodate-lysine-paraformaldehyde (PLP) fixative [33] and used for 
immunocytochemistry . 
Light and Electron Microscopy For light-microscopic obser-
vation, semithin sections of Epon resin-embedded samples (see 
below) stained with Richardson's solution [34] or paraffin-
embedded hematoxylin and eosin-stained sections were used. For 
electron microscopy, tissue samples were fixed with half-strength 
Karnovsky fixative [35] and 1.3% osmium tetroxide. After en bloc 
staining with uranyl acetate, these samples were dehydrated with 
ethanol and embedded in Epon as described previously [36]. Ul-
trathin sections were stained with uranyl acetate and lead citrate. 
Light Microscopic Immunohistochemistry In order to estab-
lish the nature and distribution ofkeratins expressed in epidermoly-
tic hyperkeratosis skin, light-microscopic immunohistochemistry 
was performed in six patients and one fetus with epidermolytic 
hyperkeratosis (Table I), by using a panel of anti-keratin antibodies 
(Table II) . Frozen skin samples from three patients (cases 2, 4 , and 8) 
and one fetus with epidermolytic hyperkeratosis and four normal 
subjects, and conjunctiva and cultured keratinocytes from case 8 
were processed for indirect immunofluorescence microscopy as de-
scribed previously [37] . Cryostat sections were incubated with anti-
keratin antibodies. To visualize the primary antibody, fluorescein-
conjugated secondary antibodies (ICN ImmunoBiologicals, Lisle, 
IL) were used. Light-microscopic immunolabeling was also per-
formed on Lowicryl resin-embedded skin samples from four epider-
moly tic hyperkeratosis cases (cases 5-8) and four normal human 
subjects. Skin samples from case 5 and one normal subject were fixed 
in PLP fixative and free aldehyde groups were quenched with 
100 mM glycine in phosphate-buffered saline; the other samples 
were not chemically fixed. Cryofixation, freeze substitution, and 
embedding in Lowicryl KIIM resin were performed using a KF-80 
freeze plunging apparatus and a CS-auto freeze substitution appa-
ratus (Reichert Jung, Vienna, Austria) as described previously [38]. 
One-micrometer semithin sections were incubated with keratin an-
tibodies. This was followed by further incubation with 1 nm colloi-
dal gold-conjugated secondary antisera (Janssen Life Science Prod-
ucts, Olen, Belgium). For light-microscopic observation, gold 
particles were enlarged by si lver staining as previously described 
[39] and sections were counter-stained with hematoxylin . 
For negative control studies, conditioned medium from the hy-
bridoma parent myeloma cell line SP2jO-Ag14 or normal rabbit 
serum were used il1Stead of the specific primary antibodies. As posi-
tive controls for the hyperproliferative keratin (K16) antibody, a 
biopsy of epidermis from a healing wound, after skin abrasion, was 
Table II. Antibodies Used for Immunocytochemistry 
Antibody 
LL017 
RbaKI 
RbaK5 
CAM5.2 
LHPI 
DEKI0 
LLOOl 
LL002 
Ks8.12 
LL025 
E3 
C46 
DA7 
LP2K 
Ig Type 
Murine IgM 
Rabbit polyclonal 
Rabbit Polyclonal 
Murine IgG2a 
Murine IgGI 
Murine IgGI 
Murine IgG2a 
Murine IgG3 
Murine IgGI 
Murine IgG I 
Murine IgG2b 
Murine IgGI 
Murine IgGI 
Murine IgG2b 
• Leigh 1M (unpublished data). 
bLanc EB (unpublished data). 
, Bartek J (personal communication). 
Reactivity 
Kl (C-terminus) 
Kl (C-tcrminus) 
K5 (C-terminus) 
K7, K8 
KIO 
KIO 
KI4 (C-tcrminus) 
KI4 (C-tcrminus) 
KI3/K15/KI6 
KI6 
K17 
K7/K17 
KI8 
K19 
Reference 
Leigh' 
Leigh' 
[57] 
[58,59] 
[49,60] 
[44] 
[57] 
[57] 
[60,61] 
Laneb 
[63] 
Bartek' 
[64] 
[65] 
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Figure 1. Light micrograph (Epon-resin embedded semithin section) from 
case 3 (Richardson's stain). Hyperkeratosis and acanthosis are prominent. 
Intrace llular edema is seen in the upper spinous and granular cell layers. Dark 
Intracellular granules (some of which arc marked with arrows) are evident 
above the basal cell layer. Magnification X 430. Bar, 10 j.jm. 
used. As positive contro ls for the K7, K8, K18, K19, and K17 
antibodies, skin samples containing sweat glands and hair follicles 
t?at Were known to express those keratins [40] were used, respec-
tively. 
Irnrnunoelectron Microscopy Electron microscopic immuno-
cytoc:hemistry was performed by a post-embedding method using 
Lowlcryl-embedded skin samples from cases 5 - 8, prepared as de-
scnbed above. Ultrathin sections were incubated with anti-keratin 
rntibodies (Table II). The primary incubation step was fo llowed by 
. urt?er 1I1cubation in 1-, 5-, 10-, 15-, or 30-nm colloidal gold-
cOI1J~gated secondary antisera Oanssen Life Science Products, Olen, 
~elglUm and Biocell, Cardiff, U.K.). One-nanometer gold was en-
arged by si lver enhancement for observation. For double labeling, 5 
and 15 nm, or 15 and 30 nm co lloidal gold-conjugated antisera 
;ere us~d to localize binding of the different keratin antibodies. 
he sectIOns were contrasted with uranyl acetate. For negative con-
~rol studies, conditioned medium from the hybridoma parent mye-
Oma cell line SP2/0-AgI4 or normal rabbit serum were used in-
stead of the specific primary antibodies. 
RESULTS 
Light Microscopy Skin from all epidermolytic hyperkeratosis 
Ptlents showed characteristic epidermal changes including acan-
~ 10SIS, papillomatosis, hyperkerarosis, vacuol ization of upper epi- · 
ermal cell s, hypergranulosis, and suprabasal presence of coarse in-
tracellular granules (Fig lA). Histologic features of the 
~ldermo lytic hyperkeratosis fetus were reported previously [27]. 
b r~~f\y,. there was vacuolization associated with dense cytoplasmic 
o les 111 the intermediate layers. 
;lectron Microscopy Findings in all epidermolytic hyperkera-
s~SI?atlents (including the one with localized disease, case 7) were 
c 1111 ar. The coarse intracellular bodies observed under light micros-
Opy Were identified as both aggregated tonofilaments and large 
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keratohyalin granules by electron microscopy. The tonofilament 
aggregates were mainly distributed from the suprabasal cells to the 
cornified cells (Fig 2A). Only rarely did some basal cells, of a distinct 
morphology with a narrow base (possibly suggesting that these cells 
were leaving the basal cell layer), show unusually thick tonofila-
ment bundles. In the lower spinous cells, the filament aggregation 
was observed as thickened bundles; in the upper layers it took the 
form of variably shaped clumps of tightly packed filaments . Kerato-
hyalin granules, with typical high electron density, appeared in 
close association with both clumped and unclumped tonofilaments. 
Some keratohyalin granules were very large, even more than 10 J.l.m 
in diameter, and had rather smooth edges in contrast to the irregular 
shape of smaller ones. Some of the large keratohyalin granules 
seemed to be associated with the abnormal filament aggregates. 
Tonofilament aggregates were also found suprabasally in cutane-
ous adnexal epithelia, including the infundibular part of outer hair 
root sheath (Fig 2B), the sebaceous ducts, and the dermal sweat 
ducts (Fig 2C). Tonofilament abnormalities were not found in other 
epithelia in the skin including the lower part of the outer hair root 
sheath, the secretory portion of the sweat gland, or the bodies of the 
sebaceous gland . The intermediate filaments of Merkel cells were of 
normal morphology. In the fetus with epidermolytic hyperkerato-
sis, tonofilaments in the intermediate layers were aggregated even 
in areas w here keratohyalin granules had not yet formed (for more 
details see [27]). In the conjunctival epithelium of a BCIE case, 
tonofilaments appeared normal. Keratinocytes from BCIE skin cul-
tured to confluence showed stratification, small numbers of kerato-
hyalin granules, and the formation of cornified envelopes, but no 
evidence of tonofilament aggregation. 
Light Microscopic Immunocytochemistry Antibodies to K5 
and K14 stained the basal and suprabasallayers in both epidermoly-
tic hyperkeratosis and normal skin (Fig 3A,D) . The labeling inten-
sity of the K14 antibodies was greatest in the basal cells, although 
relatively stronger suprabasal staining was seen in the epidermolytic 
hyperkeratosis samples compared to normal skin. Labeling with Kl 
and KI0 antibodies was seen only suprabasally in both epidermoly-
tic hyperkeratosis and normal skin (Fig 3B,E). K16 staining was 
noted suprabasally in epidermolytic hyperkeratosis skin, but was not 
found in normal epidermis. Ks8 .1 2 antibody, which reacts with 
K13, K15 and K16, stained the basal cells in all cases, but in 3 of 5 
epidermolytic hyperkeratosis samples tested, the suprabasal cells 
were also stained (Fig 3C,F). Immunolabeling of the other keratins 
K7, K8, K17, K18, and K19 was not detected in either normal or 
epidermolytic hyperkeratosis epidermal keratinocytes, except in the 
epidermolytic hyperkeratosis fetal skin, in which the basal cells 
were stained with K19 antibody. In cOI~unctival epithelium and in 
cu ltured keratinocytes the keratin expression pattern was similar to 
that of normal individuals [41-43] with little or no detectable Kl or 
KI0 labeling in both samples. 
Immunoelectron Microscopy Antibodies against keratins that 
had been positively detected in epidermolytic hyperkeratosis epider-
mis by light-microscopic immunohistochemistry were subse-
quently used for immunoelectron microscopy. However, we did 
not include LL017 or LL025, because we did not find any immuno-
reactivity with these antibodies by post-embedding immunoelec-
tron microscopy using Lowicryl KI1M, even in positive control 
specimens. In the basal cells of epidermolytic hyperkeratosis epider-
mis, the intracellular distribution of keratin immunoreactivity ap-
peared normal, with even labeling distribution on tonofilament 
networks. However, in the spinous and granular cells that contained 
tonofilament aggregates, there was intracell ular segregation of ker-
atin immunostaining, with the immunoreactivity of the aggregated 
filaments differing from that of non-aggregated ones. Strong im-
munolabeling for Kl and KI0 (detected by using antibodies RbaKl, 
LHPl, and DE-KI0) was present in both aggregated and non-
aggregated keratin filaments , but labeling for K5 or K14 (with 
LLOOl, LL002, and RbaK5 antibodies) was variable and often 
greatly reduced or completely absent in the compact aggregates of 
keratin filaments, even though these aggregates were often con-
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Figure 2. (A - C) Electron micrographs from case 8. (A) Epidermis: aggregation of tonofilaments (arrows) is noted in the suprabasal cell s, but not evident in 
adjacent basal cells (B). M, melanocyte. D, dermis. Magnification X 5,500. Bar, 5 f1m. (B) Infundibular part of outer hair root sheath. Clumped tonofilaments 
are distributed in the intermediate layers (arrows). Arrowheads, basement membrane. Star, hair canal. X 1,800. [lISet, higher magnification of the area marked 
with an asterisk. X 8,000. Bar, 2 f1m. (C) Dermal sweat duct. Two distinct aggregates of keratin filaments are shown in the intermediate layers of the ductal wall 
(arrows). Arrowheads, basement membrane. L, sweat duct lumen. X 3,300. Inset, higher magnification of one central tonofilament clump. Note the connection 
to a desmosome (d). X 26,000. Bar, 1 f1m. 
nected with more loosely compacted keratin filaments showing 
positive immunoreactivity (Fig 4) . Similar findings were noted with 
Ks8.12 antibody labeling. In the keratinocytes from normal skin, 
none of the keratin antibodies showed such a segregated staining 
pattern within individual· keratinocytes. 
DISCUSSION 
Although the clinical severity of epidermolytic hyperkeratosis may 
be very variable, primary involvement of epithelia other than skin, 
such as oral mucosa or conjunctiva, has not been reported (for re-
view see [11 D. Therefore, it is possible that the cytoskeletal abnor-
mality in epidermolytic hyperkeratosis does not involve a large 
range of keratins , but selectively includes a keratin or keratins that is 
(are) preferentially expressed in skin. The histologic distribution of 
the tonofilament abnormality associated with epidermolytic hyper-
keratosis has not been fully documented. In the present study we 
found tonofilament clumps in the suprabasal layers of various cuta-
neous epithelia including epidermis, follicular infundibulum (upper 
outer root sheath), sebaceous ducts, and sweat ducts - all sites being 
consistent with the distribution of keratins Kl and KI0, as shown 
previously [40,44- 47]-and by our immunohistochemical find-
ings. In addition, we did not detect tonofilament clumping in epi-
dermolytic hyperkeratosis conjunctiva, a tissue that does not nor-
mally express Kl or KI0 [41] . Kl/KI0 are also known to be 
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Fi~ure 3. Light micrographs of keratin immunohistochemistry. Immunogold-silver staining is shown on Lowicryl-embedded sections of unfixed normal 
skin (A-C) and epidermolytic hyperkeratosis skin, case B (D-F). LL002 (K14) staining is shown inA andD and LHP1 (K10) inB and E. In normal skin (A) , 
labehng is heavy in the basal layer and slight in the lower spinous cells. In epidermolytic hyperkeratosis (D) suprabasal expression is stronger than in normal 
sktn and patchy labeling is seen up to the granular cell layers. In both normal skin (B) and epidermolytic hyperkeratosis skin (E) , staining is evident in 
suprabasal cell layers up to the cornified cell layers. Dermo-epidermal junction is indicated with broken lines. Staining with KB.12 (K13, K15, K16) is shown in 
C andF. In normal skin (C) there is staining of only basal cells, but in epidermolytic hyperkeratosis skin (F), additional staining is seen in the upper epidermis. 
Magnification X 270. Bar, 10 f.J.m. 
e[ Xpressed in the intermediate cells of a mid-trimester fetal epidermis 
40,48,49] and it has been reported that the epidermis of an epider-
moly tiC hyperkeratosis-affected fetus at this stage of development 
also shows tononlament abnormalities [25] . The epidermolytic hy-
perkeratosis fetus examined in the present study showed tononla-
I~ent ~ggregation as reported previously [27] and Kl/Kl0 expres-
SIOn 111 the intermediate cells. The absence of tononlament 
bggregates in epidermolytic hyperkeratosis keratinocytes cultured 
y a conventional feeder layer method may reflect the low level of 
Kl/K10 expression in these cells, as has been shown in cultures of 
nor~al keratinocytes [42,43]. 
Biochemical analysis of keratins expressed in epidermolytic hy-
Phrkeratosis has been reported by two groups [23 - 25] and showed 
t at 67-kD and 64-kD keratins were absent and replaced by 62-kD 
alfd 60-kD proteins in one patient [25] and that there was an absence 
o a 55~k.D keratin in seven patients [23,24]. Because of the inherent 
llipreclslon in categorizing different molecular weight keratins by 
~ ectrophoresis, these keratins may correspond to K 1 (68 kD) or . 
~O (56.5 kD) or to their proteolytic products. Immunohistoche-
IlHcal studies [50] showed different patterns of keratin expression in 
~o epldermolytic hyperkeratosis patients. One patient receiving 
reat~ent with oral retinoid had persistence of patchy suprabasal 
sta\nl11.g using a keratin antibody that stains only basal cells in nor-
~a tkl11 and expression of hyperproliferative keratins in the supra-
b asa cells. The other patient showed absent immunostaining of 
c a~tl . cells with three different keratin antibodies that stain basal 
De s In normal skin. In the present study, we obtained rather uni-
orm results in seven patients and one fetus with epidermolytic 
hyperkeratosis by immunohistochemistry. As demonstrated in Fig 
3, the immunostaining pattern of epidermolytic hyperkeratosis epi-
dermis with antibodies to the major epidermal keratins Kl (LL017 
and RbaKl), K5 (RbaK5), Kl0 (LHP1, DE-Kl0), and K14 (LL001, 
LL002) was similar to normal control skin. LL025 (K16 antibody) 
immunoreactivity was found in epidermolytic hyperkeratosis su-
prabasal cells, but not in normal epidermis. Ks8.12 (K13/K15/ 
K16) staining was found in the basal cells in all normal and epider-
moly tic hyperkeratosis samples tested, but was also observed in 
suprabasal cells in three epidermolytic hyperkeratosis samples. The 
suprabasal staining of LL025 and Ks8.12 in epidermolytic hyper-
keratosis is consistent with a high epidermal turnover in epidermo-
lytic hyperkeratosis [26], because K16 is generally expressed in su-
prabasal cells in hyperproliferative conditions such as psoriasis 
l43 ,51], and both of these antibodies have been shown to stain the 
suprabasal cells in such conditions (Lane et al (unpublished), [52]). 
LP2K (K19) staining was found only in the basal cells of the fetus 
with epidermolytic hyperkeratosis, but similar positive staining has 
also previously been observed in a normal fetus of similar gestational 
age [49]. Other antibodies against K7, K8, K17, and K18 did not 
label either epidermolytic hyperkeratosis or normal epidermal kera-
tinocytes. 
Thus, these immunohistochemical studies show that the distri-
bution of epidermal keratins in epidermolytic hyperkeratosis is the 
same as in normal human skin, with K5/K14 expression in both 
basal and suprabasal cells and Kl/Kl0 being expressed suprabasally. 
The hyperproliferative keratin labeling is similar to that seen in 
other high-turnover dermatoses such as psoriasis. In addition, there 
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Figure 4. Keratin expression in epidermolytic hyperkeratosis as detected by immunoelectron microscopy. (A) LHP1 (K10) labeling of the granular cell layer 
from case 8 using a I-nm immunogold-silver staining method. Heavy labeling is seen in the compact aggregation of tonofilaments (c), as well as in the 
non-aggregated or only partially aggregated filaments (arrows). Asterisk, keratohyalin granule. In Lowicryl-resin-embedded samples, keratohyalin granules 
usually appear as clearly defined areas of low electron density granular material as shown in this figure. The identity of these granules was confirmed by positive 
immunolabeling with anti-filaggrin antibodies (data not shown). d, desmosome. Magnification X 18,000. Bar, 1 }lm. (B) LLOOI (KI4) labeling of a spinous 
cell from case 6 using a 1-nm immunogold-silver staining method. The clump of tightly packed fine filaments (c) is not labeled although it is continuous with 
the heavily immunolabeled loosely aggregated tonofilament bundles. X 33,000. Bar, 0.5 }lm. (C) Double labeling using RbaKI (anti-K1 serum) and LLOOI 
(anti-K14 antibody) in a spinous cell from case 8. Note that K1 (30 nm gold) and K14 (15 nm gold) are co-expressed in the non-aggregated or only partially 
aggregated tonofilaments (left of figure). In contrast, the compactly aggregated filaments (c) have minimal K141abeling but denser K1labeling. X 32,000. Bar, 
0.5 }lm. n, nucleus. 
is no evidence for aberrant expression of simple epithelial keratins in 
epidermal keratinocytes. All these findings suggest that the mecha-
nism of keratin filament disorganization in epidermolytic hyper-
keratosis does not involve an altered sequence of expression of epi-
dermal keratins related to differentiation or an aberrant expression 
of other keratins. A quantitative abnormality of epidermal keratins 
also seems unlikely, because over-expression of a normal Kl4 mole-
cule in transfected epithelial cells [53) or in transgenic mice [29) did 
not cause any morphologic cytoskeletal disorganization; however, 
the unique character of the large "sticky" head and tail domains of 
Kl and KlD [54] could conceivably lead to peculiar aggregates if 
these keratins were overexpressed. The most likely explanation to 
account for the filament abnormality in epidermolytic hyperkerato-
sis is probably some qualitative abnormality in these keratins. Inter-
estingly, mutations of Kl4 genes have been reported to cause a 
dramatic perturbation of the keratin filament network both in vivo 
and in vitro [29,53]. 
If the underlying abnormality of epidermolytic hyperkeratosis is 
caused by keratin gene mutations, which keratin(s) is (are) the most 
likely to be involved? We have found that the tissue distribution of 
the tonofilament aggregates follows the distribution pattern ofKi/ 
KiD. Additionally, immunoelectron microscopy revealed that the 
tonofilament aggregates of four epidermolytic hyperkeratosis cases 
from three unrelated families showed strong immunoreactivity to 
anti-Ki and -KiD antibodies but not to other keratin antibodies that 
stained non-aggregated filaments in the same samples. Therefore, 
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either K 1 or Kl D or both of these keratins seem to be the most likely 
keratins to be implicated in the etiology of epidennolytic hyperker-
atosis. 
Some other molecules have also been reported to be expressed 
abnormally in epidermolytic hyperkeratosis skin. Reduced Q -
mannosidase levels have been found in two BCIE patients [12,22] . 
Involucrin expression has been found to be increased in one patient 
with BCIE, in six epidermal nevi with histologic features of epider-
moly tic hyperkeratosis, and in various other unrelated skin diseases 
[55]. Immunoautoradiographic studies in an epidermolytic hyper-
keratosis patient have shown filaggrin-immunoreactive proteins of 
lower (- 15 kD) and higher (- 70 kD) molecular weight in addi-
tion to normal 35-kD proteins [25] . Filaggrin is a particularly inter-
esting molecule, because it is believed to be involved in the aggrega-
tion of keratin filaments [56] . However, it is unlikely that the 
characteristic aggregation of keratin filaments in epidermolytic hy-
perkeratosis is caused by premature interaction with filaggrin mole-
cules, which usually takes place during cornification, because the 
fil ament aggregates are seen in the cells lacking keratohyalin gran-
ules (the storage sites of the filag grin precursors), as mentioned in 
the introduction. In addition, our preliminary immunoelectron mi-
croscopical studies revealed that the aggregated tonofilaments in 
epi?ermolytic hyperkeratosis were not stained with anti-filaggrin 
antibodies (presented at the joint meeting of the Society for Cutane-
ous Ultrastructure Research and the Japanese Society for Ultrastruc-
tural Cutaneous Biology, May, 1991; manuscript in preparation). 
The possibility of involvement of molecules other than keratin in 
the etiology of epidermolytic hyperkeratosis cannot be excluded, 
particularly because epidermolytic hyperkeratosis might be geneti-
cally heterogeneous, which might account for the variable pheno-tyte. However, our present studies suggest that whatever the nature 
o the underlying gene abnormality, the keratins involved in the 
malI1 cytoskeletal changes are K1 and K10. These findings should 
encourage molecular and cell biologic studies to determine whether 
transgenic mice, bearing mutations for the K1 or K1D gene, show 
epldermolytic changes corresponding to the human disorder, or 
whether linkage can be established between individuals affected 
with epidermolytic hyperkeratosis (or BCIE) and the K1 and K1D 
gene loci. 
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